Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
ACS Chemical Neuroscience
|
March 20, 2024
Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders
Sydney J Risen, Sean W Boland, Sadhana Sharma, et al.
British Journal of Haematology
|
October 15, 2024
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa
Catherine I Segbefia, Luke R Smart, Susan E Stuber, et al.
Acta Haematologica
|
August 17, 2022
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa
Luke R Smart, Emmanuela E Ambrose, Georgina Balyorugulu, et al.
Plos Genetics
|
January 7, 2017
Genomes of Fasciola hepatica from the Americas Reveal Colonization with Neorickettsia Endobacteria Related to the Agents of Potomac Horse and Human Sennetsu Fevers
Samantha N McNulty, Jose F Tort, Gabriel Rinaldi, et al.
Cancer Research
|
March 5, 2020
Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling
Jian Chen, Abhisek Mitra, Shulin Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 8, 2025
Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular Carcinoma
Xiyan Xiang, Kirti Shetty, Herbert Yu, et al.
Blood Advances
|
September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations
Alexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.
Genes & Cancer
|
February 7, 2024
Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis
Xiyan Xiang, Krishanu Bhowmick, Kirti Shetty, et al.
Trials
|
November 28, 2020
Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia
Emily R Meier, Susan E Creary, Matthew M Heeney, et al.
NEJM Evidence
|
December 8, 2024
Hydroxyurea for Children and Adults with Hemoglobin SC Disease
Yvonne A Dei-Adomakoh, Catherine I Segbefia, Teresa S Latham, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
ACS Chemical Neuroscience
|
March 20, 2024
Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders
Sydney J Risen, Sean W Boland, Sadhana Sharma, et al.
British Journal of Haematology
|
October 15, 2024
Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa
Catherine I Segbefia, Luke R Smart, Susan E Stuber, et al.
Acta Haematologica
|
August 17, 2022
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa
Luke R Smart, Emmanuela E Ambrose, Georgina Balyorugulu, et al.
Plos Genetics
|
January 7, 2017
Genomes of Fasciola hepatica from the Americas Reveal Colonization with Neorickettsia Endobacteria Related to the Agents of Potomac Horse and Human Sennetsu Fevers
Samantha N McNulty, Jose F Tort, Gabriel Rinaldi, et al.
Cancer Research
|
March 5, 2020
Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling
Jian Chen, Abhisek Mitra, Shulin Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 8, 2025
Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular Carcinoma
Xiyan Xiang, Kirti Shetty, Herbert Yu, et al.
Blood Advances
|
September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations
Alexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.
Genes & Cancer
|
February 7, 2024
Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis
Xiyan Xiang, Krishanu Bhowmick, Kirti Shetty, et al.
Trials
|
November 28, 2020
Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia
Emily R Meier, Susan E Creary, Matthew M Heeney, et al.
NEJM Evidence
|
December 8, 2024
Hydroxyurea for Children and Adults with Hemoglobin SC Disease
Yvonne A Dei-Adomakoh, Catherine I Segbefia, Teresa S Latham, et al.
Page
of 11